Business

Arrayed CRISPR Screening Market Presents Lucrative Opportunities Through 2026-2030: Total Revenue to Grow by $1.64 Billion at 17.7% CAGR

Industry poised for growth, driven by advancements in precision drug discovery, rising gene therapy investments, and personalized medicine adoption Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Report 2026" has been added

articleCrispr Therapeutics AgApril 20, 20264/company/crispr-therapeutics-ag/news/arrayed-crispr-screening-market-presents-lucrative-opportunities-through-2026-2030-total-revenue-to-grow-by-dollar164-billion-at-177percent-cagr
Arrayed CRISPR Screening Market Presents Lucrative Opportunities Through 2026-2030: Total Revenue to Grow by $1.64 Billion at 17.7% CAGR

About this update from Crispr Therapeutics Ag

[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"Industry poised for growth, driven by advancements in precision drug discovery, rising gene therapy investments, and personalized medicine adoption","length":147,"tagName":"p"},{"type":"text","content":"Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market","length":91,"tagName":"p"},{"type":"image","alt":"Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market","displaySize":"","headline":null,"caption":"Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/en/globenewswire.com/0396d865d2e7975c7923e86cab6bba42"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Qzc8t6EPQpHSg0gMu68hxg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MA--/https://media.zenfs.com/en/globenewswire.com/0396d865d2e7975c7923e86cab6bba42","width":600,"height":400}}},{"type":"text","content":"Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Report 2026" has been added to ResearchAndMarkets.com's offering.","length":220,"tagName":"p"},{"type":"text","content":"The CRISPR screening market is experiencing significant growth and is forecasted to expand from $1.52 billion in 2025 to $1.79 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.5%. This expansion is attributed to the progress in functional genomics research, the availability of CRISPR editing reagents, academic screening programs, and increased use of cell-based assays.","length":393,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"wid...

More updates from Crispr Therapeutics Ag

Clustered Regularly Interspaced Short Palindromic Repeatscompound annual growth rategenetic diseasesgene therapy researchFunctional Genomics Screening Laboratoryfunctional genomics researchThermo Fisher Scientific Incscreening programspersonalized treatmentsGE HealthCare Technologies IncMedical Research Councildrug discovery